Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase I (Q41937377)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 2009
edit
Language Label Description Also known as
English
Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase I
scientific article published on November 2009

    Statements

    Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase I (English)
    Eva C Koffeman
    Mark Genovese
    Diane Amox
    Elissa Keogh
    Ernesto Santana
    Eric L Matteson
    Jerry A Molitor
    Michael H Schiff
    James O Posever
    Joan M Bathon
    Alan J Kivitz
    Rodrigo Samodal
    Francis Belardi
    Carolyn Dennehey
    Femke van Wijk
    Xiao Zhang
    Peter Zieseniss
    Berent A Prakken
    Salvatore Albani
    1 November 2009
    3207-3216

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit